MedPath

LIZELLE 0.02mg/3mg film-coated tablet

Registration Number: MAL12085077AZ

Approved
Approval ID

fbb3b3096b04e195

Registration Number

MAL12085077AZ

Registration Date

Jul 7, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 7, 2025

PACKAGING INFORMATION (1)

21tablet TabletsAvailable
Package Size: 21tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (2)

DROSPIRENONEActive
Monograph: 屈螺酮
ETHINYLESTRADIOLActive
Monograph: 炔雌醇

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIZELLE 0.02mg/3mg film-coated tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform